Genetic Mutation Increases Survival Time for Mesothelioma Patients
Dr. Michele Carbone and other researchers find the BAP1 gene, which increases risk of mesothelioma, also can boost survival time in some patients.
Mesothelioma Survivor Credits Cannabis Oil Treatment to His Recovery
After Andy Ashcraft’s mesothelioma clinical trial drug stopped working, he turned to cannabis oil. The 68-year-old credits the treatment to his survival.
New Skin Cancer-Fighting Drug Keytruda Boosts Mesothelioma Survival
Help could be on the way for future mesothelioma patients who need it the most.
Researchers in Spain are the first to successfully identify a specific protein found only in mesothelioma patients with the shortest survival times.
The findings should pro…
Surgeon David Mason Building Thoracic Program at Baylor in Dallas
David Mason, chief of thoracic surgery and transplantation at Baylor University Medical Center, is building a new program with multiple cancer specialists.
Brigham and Women’s Study Shows Benefits of EPP Mesothelioma Surgery
Despite the ongoing debate over the aggressive extrapleural pneumonectomy, a new study shows it remains a viable option for some mesothelioma patients.
Brigham and Women’s Study Shows Benefits of EPP Mesothelioma Surgery
Despite the ongoing debate over the aggressive extrapleural pneumonectomy, a new study shows it remains a viable option for some mesothelioma patients.
Component in Asian Spice Could Slow Mesothelioma Tumor Growth
Researchers at Case Western Reserve University say curcumin, a component of the spice turmeric, may slow tumor growth in mesothelioma patients.
Pacific Heart, Lung & Blood Institute to Hold Mesothelioma Fundraiser
The Pacific Heart, Lung & Blood Institute in California will hold its third annual mesothelioma fundraiser in October to raise money for cancer research.
Georgia Regents University Launches Immunotherapy Clinical Trial
Researchers at Georgia Regents University Cancer Center are accepting mesothelioma patients who want to participate in an immunotherapy clinical trial.
Aggressive Therapy Shows Hope for Peritoneal Mesothelioma Patients
Researchers found that repeating the debulking and HIPEC procedure in some peritoneal mesothelioma patients two or three times can extend survival.
Surgeons Make Cancer Cells Glow Bright Green to Reduce Recurrence
Researchers at the Perelman School of Medicine are using a dye and near-infrared light to make cancer cells glow to reduce cancer recurrence.
Using Light Energy to Kill Mesothelioma Cancer Cells
A clinical trial at the Ohio State University Comprehensive Cancer Center will use photodynamic therapy to kill cancer cells in mesothelioma patients.
Carboplatin Remains the Best Chemotherapy Drug for HIPEC Procedure
A 2014 Creighton University Medical Center study shows that chemotherapy drug carboplatin is the best option for peritoneal mesothelioma undergoing a HIPEC procedure.
Clinical Trial Will Test if Vaccine Can Prevent, Delay Cancer Recurrence
Researchers at the National Institutes of Health will be testing an immunotherapy vaccine on patients to see if it will prevent or delay cancer recurrence.
Young Cancer Patient’s Tenacity Inspires Family, Friends and Strangers
While Jimmy E. fights for his life after a second cancer diagnosis, his experience and tenacity is an inspiration to family, friends and strangers.